| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P< 0.05 compared to WHO criteria. † p < 0.05 compared to NCEP-ATP III criteria. p < 0.05 compared to NCEP-ATP III criteria. |
Research Article
A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions
Table 5
General characteristics of the subjects with metabolic syndrome according to the three definitions.